{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:57:59Z","timestamp":1792803479699,"version":"4.5.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jacc.2018.05.044","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T14:09:30Z","timestamp":1532959770000},"page":"662-680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":593,"title":["Clinical Genetic Testing for Familial\u00a0Hypercholesterolemia"],"prefix":"10.1016","volume":"72","author":[{"given":"Amy C.","family":"Sturm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua W.","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S.","family":"Gidding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid S.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine D.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth J.","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mafalda","family":"Bourbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Carri\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cuchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah D.","family":"de Ferranti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep C.","family":"Defesche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Freiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray E.","family":"Hershberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Kees","family":"Hovingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lala","family":"Karayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes Jacob Pieter","family":"Kastelein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Kindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey R.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Leigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MacRae F.","family":"Linton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge G.","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul D.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Harada-Shiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Sijbrands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan O.","family":"Stitziel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuya","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Wilemon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Ledbetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Rader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2018.05.044_bib1","unstructured":"National Institute for Health and Care Excellence: Clinical Guidelines. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK11822\/. Accessed June 28, 2018."},{"key":"10.1016\/j.jacc.2018.05.044_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.atherosclerosissup.2011.06.001","article-title":"Familial hypercholesterolaemia: a model of care for Australasia","volume":"12","author":"Watts","year":"2011","journal-title":"Atherosclerosis Suppl"},{"key":"10.1016\/j.jacc.2018.05.044_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijcard.2013.11.025","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation","volume":"171","author":"Watts","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2018.05.044_bib4","first-page":"1471","article-title":"Canadian Cardiovascular Society position statement on familial hypercholesterolemia","volume":"30","author":"Genest","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2018.05.044_bib5","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2018.05.044_bib6","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/CIR.0000000000000312","article-title":"Further evolution of the ACC\/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"133","author":"Halperin","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.05.044_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf7000","article-title":"Genetic identification of familial hypercholesterolemia within a single U.S. health care system","volume":"354","author":"Abul-Husn","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jacc.2018.05.044_bib8","first-page":"4758","article-title":"Corrigendum to \u201cFamilial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication\u201d","volume":"99","author":"Benn","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2018.05.044_bib9","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2018.05.044_bib10","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1602777","article-title":"Child-parent familial hypercholesterolemia screening in primary care","volume":"375","author":"Wald","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.05.044_bib11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/aje\/kwh236","article-title":"Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review","volume":"160","author":"Austin","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacc.2018.05.044_bib12","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0140-6736(69)90930-1","article-title":"Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states","volume":"2","author":"Slack","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2018.05.044_bib13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.CIR.49.3.476","article-title":"Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia","volume":"49","author":"Stone","year":"1974","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.05.044_bib14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature13917","article-title":"Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction","volume":"518","author":"Do","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2018.05.044_bib15","doi-asserted-by":"crossref","first-page":"a2423","DOI":"10.1136\/bmj.a2423","article-title":"Efficacy of statins in familial hypercholesterolaemia: a long term cohort study","volume":"337","author":"Versmissen","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2018.05.044_bib16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jacc.2015.11.021","article-title":"Statin initiation during childhood in patients with familial hypercholesterolemia: consequences for cardiovascular risk","volume":"67","author":"Braamskamp","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.05.044_bib17","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/eurheartj\/ehn422","article-title":"Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study","volume":"29","author":"Neil","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.05.044_bib18","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.05.044_bib19","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.05.044_bib20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MOL.0000000000000179","article-title":"Homozygous autosomal dominant hypercholesterolaemia: prevalence, diagnosis, and current and future treatment perspectives","volume":"26","author":"Sjouke","year":"2015","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacc.2018.05.044_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1373\/clinchem.2014.231365","article-title":"Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries","volume":"61","author":"Futema","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2018.05.044_bib22","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2018.05.044_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ejhg.2015.100","article-title":"Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction","volume":"24","author":"Braenne","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jacc.2018.05.044_bib24","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/eurheartj\/ehx136","article-title":"Genetic testing for familial hypercholesterolaemia is essential in individuals with high LDL cholesterol: who does it in the world?","volume":"38","author":"Nordestgaard","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.05.044_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.05.044_bib26","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jacl.2016.05.007","article-title":"Familial hypercholesterolemia in a large ambulatory population: statin use, optimal treatment, and identification for advanced medical therapies","volume":"10","author":"Knickelbine","year":"2016","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2018.05.044_bib27","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jacl.2016.07.011","article-title":"US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry","volume":"10","author":"Ahmad","year":"2016","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2018.05.044_bib28","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.33549\/physiolres.933600","article-title":"Familial hypercholesterolemia in the Czech Republic: more than 17 years of systematic screening within the MedPed project","volume":"66","author":"Vrablik","year":"2017","journal-title":"Physiol Res"},{"key":"10.1016\/j.jacc.2018.05.044_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2004-822987","article-title":"Advanced method for the identification of patients with inherited hypercholesterolemia","volume":"4","author":"Defesche","year":"2004","journal-title":"Semin Vasc Med"},{"key":"10.1016\/j.jacc.2018.05.044_bib30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group","volume":"303","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2018.05.044_bib31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/MOL.0b013e32830636e5","article-title":"What is the clinical utility of DNA testing in patients with familial hypercholesterolaemia?","volume":"19","author":"Humphries","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacc.2018.05.044_bib32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MOL.0000000000000398","article-title":"The role of registries and genetic databases in familial hypercholesterolemia","volume":"28","author":"Kindt","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacc.2018.05.044_bib33","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1161\/CIRCULATIONAHA.116.024541","article-title":"Predicting cardiovascular events in familial hypercholesterolemia: the SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)","volume":"135","author":"Perez de Isla","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.05.044_bib34","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2016.01.008","article-title":"Attainment of LDL-cholesterol treatment goals in patients with familial hypercholesterolemia: 5-year SAFEHEART registry follow-up","volume":"67","author":"Perez de Isla","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.05.044_bib35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1399-0004.2004.00320.x","article-title":"Cascade genetic screening for familial hypercholesterolemia","volume":"66","author":"Leren","year":"2004","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacc.2018.05.044_bib36","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.05.044_bib37","first-page":"26","article-title":"Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening","volume":"11","author":"Leren","year":"2008","journal-title":"Community Genet"},{"key":"10.1016\/j.jacc.2018.05.044_bib38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2217\/clp.14.19","article-title":"Underutilization of cascade screening for familial hypercholesterolemia","volume":"9","author":"Neal","year":"2014","journal-title":"Clin Lipidol"},{"key":"10.1016\/j.jacc.2018.05.044_bib39","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2015.07.017","article-title":"Universal screening for familial hypercholesterolemia in children","volume":"66","author":"Klancar","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.05.044_bib40","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.05.044_bib41","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCGENETICS.111.962456","article-title":"Discriminative ability of LDL-cholesterol to identify patients with familial hypercholesterolemia: a cross-sectional study in 26,406 individuals tested for genetic FH","volume":"5","author":"Huijgen","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2018.05.044_bib42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/bmj.39300.616076.55","article-title":"Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis","volume":"335","author":"Wald","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2018.05.044_bib43","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1515\/CCLM.2008.135","article-title":"Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs\u00a0for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing","volume":"46","author":"Starr","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jacc.2018.05.044_bib44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(00)03587-X","article-title":"Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands","volume":"357","author":"Umans-Eckenhausen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2018.05.044_bib45","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/eurheartj\/ehx004","article-title":"Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia","volume":"38","author":"Tada","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.05.044_bib46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacl.2015.09.003","article-title":"Premature coronary heart disease and autosomal dominant hypercholesterolemia: increased risk in women with\u00a0LDLR mutations","volume":"10","author":"Ahmad","year":"2016","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2018.05.044_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2362.2003.01094.x","article-title":"Impact of genetic defects on coronary atherosclerosis in patients suspected of having familial hypercholesterolaemia","volume":"33","author":"Descamps","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacc.2018.05.044_bib48","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.atherosclerosis.2017.05.015","article-title":"Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia","volume":"263","author":"Sharifi","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2018.05.044_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archinte.163.1.65","article-title":"Long-term compliance with lipid-lowering medication after genetic screening for familial hypercholesterolemia","volume":"163","author":"Umans-Eckenhausen","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2018.05.044_bib50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-2004-822989","article-title":"Application of molecular genetics for diagnosing familial hypercholesterolemia in Norway: results from a family-based screening program","volume":"4","author":"Leren","year":"2004","journal-title":"Semin Vasc Med"},{"key":"10.1016\/j.jacc.2018.05.044_bib51","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1258\/acb.2008.008094","article-title":"Family tracing to identify patients with familial hypercholesterolaemia: the second audit of the Department of Health Familial Hypercholesterolaemia Cascade Testing Project","volume":"46","author":"Hadfield","year":"2009","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jacc.2018.05.044_bib52","unstructured":"CDC Office of Public Health Genomics Tier Table\u00a0Database. Available at: https:\/\/phgkb.cdc.gov\/PHGKB\/topicStartPage.action. Accessed June 28, 2018."},{"key":"10.1016\/j.jacc.2018.05.044_bib53","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/hrt.2010.213975","article-title":"Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies","volume":"97","author":"Nherera","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2018.05.044_bib54","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/bmj.324.7349.1303","article-title":"Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia","volume":"324","author":"Marks","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2018.05.044_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4290","article-title":"Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis","volume":"4","author":"Marks","year":"2000","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jacc.2018.05.044_bib56","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/eurheartj\/ehx111","article-title":"Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK","volume":"38","author":"Kerr","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.05.044_bib57","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacl.2014.05.008","article-title":"Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia","volume":"8","author":"Ademi","year":"2014","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2018.05.044_bib58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2004-822992","article-title":"Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands","volume":"4","author":"Wonderling","year":"2004","journal-title":"Semin Vasc Med"},{"key":"10.1016\/j.jacc.2018.05.044_bib59","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jacl.2017.01.002","article-title":"Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia","volume":"11","author":"Lazaro","year":"2017","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2018.05.044_bib60","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/bmj.321.7275.1497","article-title":"Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia","volume":"321","author":"Bhatnagar","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2018.05.044_bib61","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.atherosclerosis.2011.07.106","article-title":"Reduced penetrance of autosomal dominant hypercholesterolemia in a high percentage of families: importance of genetic testing in the entire family","volume":"218","author":"Garcia-Garcia","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2018.05.044_bib62","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/humu.21660","article-title":"Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl Levels","volume":"33","author":"Huijgen","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacc.2018.05.044_bib63","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/ATVBAHA.114.304406","article-title":"PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study","volume":"34","author":"Saavedra","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2018.05.044_bib64","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cca.2015.12.028","article-title":"A\u00a0de novo mutation of the LDL receptor gene as the cause of familial hypercholesterolemia identified using whole exome sequencing","volume":"453","author":"Tada","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacc.2018.05.044_bib65","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.jacl.2016.09.003","article-title":"Double-heterozygous autosomal dominant hypercholesterolemia: clinical characterization of an underreported disease","volume":"10","author":"Sjouke","year":"2016","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2018.05.044_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2013.271","article-title":"Clinical utility gene card for: hyperlipoproteinemia, type II","volume":"22","author":"Kassner","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jacc.2018.05.044_bib67","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCULATIONAHA.113.001292","article-title":"Lomitapide and mipomersen: two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia","volume":"129","author":"Rader","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.05.044_bib68","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S2213-8587(17)30044-X","article-title":"Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study","volume":"5","author":"Raal","year":"2017","journal-title":"Lancet Diabets Endocrinol"},{"key":"10.1016\/j.jacc.2018.05.044_bib69","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCGENETICS.115.001129","article-title":"Characterization of autosomal dominant hypercholesterolemia caused by PCSK9 gain of function mutations and its specific treatment with alirocumab, a PCSK9 monoclonal antibody","volume":"8","author":"Hopkins","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2018.05.044_bib70","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(14)61374-X","article-title":"Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2018.05.044_bib71","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajhg.2015.05.022","article-title":"Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents","volume":"97","author":"Botkin","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacc.2018.05.044_bib72","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/jama.2014.8892","article-title":"Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia","volume":"312","author":"Kusters","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2018.05.044_bib73","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2012.10.032","article-title":"Statin treatment of children with familial hypercholesterolemia\u2014trying to balance incomplete evidence of long-term safety and clinical accountability: are we approaching a consensus?","volume":"226","author":"Vuorio","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2018.05.044_bib74","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/bmj.328.7438.500","article-title":"Effect of statin treatment for familial hypercholesterolaemia on life assurance: results of consecutive surveys in 1990 and 2002","volume":"328","author":"Neil","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2018.05.044_bib75","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1136\/jmg.39.9.e49","article-title":"Parental attitude towards genetic testing for familial hypercholesterolaemia in children","volume":"39","author":"Umans-Eckenhausen","year":"2002","journal-title":"J\u00a0Medic Genet"},{"key":"10.1016\/j.jacc.2018.05.044_bib76","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ajmg.a.30102","article-title":"Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial","volume":"128A","author":"Marteau","year":"2004","journal-title":"Am J Med Genet Part A"},{"key":"10.1016\/j.jacc.2018.05.044_bib77","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pec.2011.09.002","article-title":"How do index patients participating in genetic screening programmes for familial hypercholesterolemia (FH) interpret their DNA results? A UK-based qualitative interview study","volume":"90","author":"Jenkins","year":"2013","journal-title":"Patient Educ Counseling"},{"key":"10.1016\/j.jacc.2018.05.044_bib78","first-page":"45","article-title":"A\u00a0qualitative study of patients' perceptions of the value of molecular diagnosis for familial hypercholesterolemia (FH)","volume":"8","author":"Hallowell","year":"2017","journal-title":"J\u00a0Commun Genet"},{"key":"10.1016\/j.jacc.2018.05.044_bib79","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/13548506.2011.644246","article-title":"Being at risk for cardiovascular disease: perceptions and preventive behavior in people with and without a known genetic predisposition","volume":"17","author":"Claassen","year":"2012","journal-title":"Psychol Health Medicine"},{"key":"10.1016\/j.jacc.2018.05.044_bib80","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/ajmg.a.32592","article-title":"Predictive genetic testing for cardiovascular diseases: impact on carrier children","volume":"146A","author":"Meulenkamp","year":"2008","journal-title":"Am J Med Genet Part A"},{"key":"10.1016\/j.jacc.2018.05.044_bib81","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ajmg.a.32218","article-title":"Health-related quality of life of children with a positive carrier status for inherited cardiovascular diseases","volume":"146A","author":"Smets","year":"2008","journal-title":"Am J Med Genet Part A"},{"key":"10.1016\/j.jacc.2018.05.044_bib82","first-page":"1","article-title":"Recent advances in genetic testing for familial hypercholesterolemia","author":"Iacocca","year":"2017","journal-title":"Exp Rev Molecular Diagnostics"},{"key":"10.1016\/j.jacc.2018.05.044_bib83","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1399-0004.2009.01356.x","article-title":"Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot CASCADE project","volume":"77","author":"Taylor","year":"2010","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacc.2018.05.044_bib84","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/jmg.2006.038356","article-title":"Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk","volume":"43","author":"Humphries","year":"2006","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jacc.2018.05.044_bib85","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/gim.2017.151","article-title":"Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis","volume":"20","author":"Chora","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.jacc.2018.05.044_bib86","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/humu.20105","article-title":"LDL-receptor mutations in Europe","volume":"24","author":"Dedoussis","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacc.2018.05.044_bib87","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jmedgenet-2016-104054","article-title":"The UCL low-density lipoprotein receptor gene variant database: pathogenicity update","volume":"54","author":"Leigh","year":"2017","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jacc.2018.05.044_bib88","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1399-0004.2009.01168.x","article-title":"Multiplex ligation-dependent probe amplification analysis to screen for deletions and duplications of the LDLR gene in patients with familial hypercholesterolaemia","volume":"76","author":"Taylor","year":"2009","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacc.2018.05.044_bib89","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2013.01.007","article-title":"Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy","volume":"227","author":"Bertolini","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2018.05.044_bib90","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-2350-11-115","article-title":"Genomic characterization of large rearrangements of the LDLR gene in Czech patients with familial hypercholesterolemia","volume":"11","author":"Goldmann","year":"2010","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jacc.2018.05.044_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(93)90171-P","article-title":"Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia","volume":"104","author":"Myant","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2018.05.044_bib92","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/geno.1997.4898","article-title":"Estimation of the age of the ancestral arginine3500-->glutamine mutation in human apoB-100","volume":"45","author":"Myant","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.jacc.2018.05.044_bib93","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jacl.2016.09.009","article-title":"Familial defective apolipoprotein B-100: a review","volume":"10","author":"Andersen","year":"2016","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2018.05.044_bib94","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/eurheartj\/ehs010","article-title":"Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia","volume":"33","author":"Motazacker","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.05.044_bib95","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/mgg3.17","article-title":"Identification and biochemical analysis of a novel APOB mutation that causes autosomal dominant hypercholesterolemia","volume":"1","author":"Thomas","year":"2013","journal-title":"Molec Genet Genomic Med"},{"key":"10.1016\/j.jacc.2018.05.044_bib96","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1172\/JCI117772","article-title":"Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity","volume":"95","author":"Pullinger","year":"1995","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2018.05.044_bib97","doi-asserted-by":"crossref","first-page":"E76","DOI":"10.1161\/01.ATV.20.10.e76","article-title":"R3531C mutation in the apolipoprotein B gene is not sufficient to cause hypercholesterolemia","volume":"20","author":"Rabes","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2018.05.044_bib98","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJM199805283382203","article-title":"Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease","volume":"338","author":"Tybjaerg-Hansen","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.05.044_bib99","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2018.05.044_bib100","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1161\/01.ATV.0000190668.94752.ab","article-title":"Severe hypercholesterolemia in four British families with the D374Y mutation in the PCSK9 gene: long-term follow-up and treatment response","volume":"25","author":"Naoumova","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2018.05.044_bib101","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jacc.2017.08.009","article-title":"Genetically confirmed familial hypercholesterolemia in patients with acute coronary syndrome","volume":"70","author":"Amor-Salamanca","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.05.044_bib102","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.atherosclerosis.2017.06.917","article-title":"Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil","volume":"263","author":"Silva","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2018.05.044_bib103","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.atherosclerosis.2015.03.003","article-title":"Clinical experience of scoring criteria for familial hypercholesterolaemia (FH) genetic testing in Wales","volume":"240","author":"Haralambos","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2018.05.044_bib104","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/CIRCULATIONAHA.110.979450","article-title":"Molecular basis of autosomal dominant hypercholesterolemia assessment in a large cohort of hypercholesterolemic children","volume":"123","author":"van der Graaf","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.05.044_bib105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCULATIONAHA.116.022335","article-title":"Long-term risk of atherosclerotic cardiovascular disease in US adults with the familial hypercholesterolemia phenotype","volume":"134","author":"Perak","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.05.044_bib106","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/eurheartj\/ehw028","article-title":"Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217","volume":"37","author":"Benn","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.05.044_bib107","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1161\/ATVBAHA.116.308027","article-title":"Polygenic versus monogenic causes of hypercholesterolemia ascertained clinically","volume":"36","author":"Wang","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2018.05.044_bib108","first-page":"565","article-title":"Selection of individuals for genetic testing for familial hypercholesterolaemia: development and external validation of a prediction model for the presence of a mutation causing familial hypercholesterolaemia","volume":"38","author":"Besseling","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.05.044_bib109","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5551\/jat.19158","article-title":"Coronary artery disease. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan\u20142012 version","volume":"21","author":"Teramoto","year":"2014","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.jacc.2018.05.044_bib110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jacc.2017.11.028","article-title":"Autosomal recessive hypercholesterolemia: long-term cardiovascular outcomes","volume":"71","author":"D'Erasmo","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.05.044_bib111","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2013.09.007","article-title":"APOE p.Leu167del mutation in familial hypercholesterolemia","volume":"231","author":"Awan","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2018.05.044_bib112","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MOL.0000000000000163","article-title":"Targeted next-generation sequencing in monogenic dyslipidemias","volume":"26","author":"Hegele","year":"2015","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacc.2018.05.044_bib113","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jacl.2016.11.002","article-title":"Lysosomal acid lipase deficiency: a hidden disease among cohorts of familial hypercholesterolemia?","volume":"11","author":"Chora","year":"2017","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2018.05.044_bib114","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1126\/science.290.5497.1771","article-title":"Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters","volume":"290","author":"Berge","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jacc.2018.05.044_bib115","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1161\/ATVBAHA.113.302426","article-title":"Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia","volume":"33","author":"Stitziel","year":"2013","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"10.1016\/j.jacc.2018.05.044_bib116","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2018.05.044_bib117","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jacl.2016.08.011","article-title":"Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: frequencies, associations and predictions","volume":"10","author":"Ellis","year":"2016","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2018.05.044_bib118","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S2213-8587(16)30042-0","article-title":"High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study","volume":"4","author":"Langsted","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2018.05.044_bib119","unstructured":"Global Variome shared LOVD LDLR (low density lipoprotein receptor). Available at: https:\/\/databases.lovd.nl\/shared\/genes\/LDLR. Accessed July 16, 2018."},{"key":"10.1016\/j.jacc.2018.05.044_bib120","unstructured":"Wallis Y. Practice Guidelines for the Evaluation of Pathogenicity and the Reporting of Sequence Variants in Clinical Molecular Genetics. Available at: http:\/\/www.acgs.uk.com\/media\/774853\/evaluation_and_reporting_of_sequence_variants_bpgs_june_2013_-_finalpdf.pdf. In: Science AfCG, editor, 2013."},{"key":"10.1016\/j.jacc.2018.05.044_bib121","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jacc.2018.05.044_bib122","doi-asserted-by":"crossref","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacc.2018.05.044_bib123","unstructured":"ClinGen FH Expert Panel. 2017. Available at: https:\/\/www.clinicalgenome.org\/working-groups\/clinical-domain\/cardiovascular-clinical-domain-working-group\/familial-hypercholesterolemia-variant-curation-expert-panel\/. Accessed June 28, 2018."},{"key":"10.1016\/j.jacc.2018.05.044_bib124","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","article-title":"ClinGen\u2014the Clinical Genome Resource","volume":"372","author":"Rehm","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.05.044_bib126","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/gim.2016.190","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics","volume":"19","author":"Kalia","year":"2017","journal-title":"Genetics Med"},{"key":"10.1016\/j.jacc.2018.05.044_bib127","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1001\/jama.2015.3419","article-title":"Why the Americans with Disabilities Act Matters for genetics","volume":"313","author":"Clayton","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2018.05.044_bib128","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MOL.0000000000000397","article-title":"Genotype-guided diagnosis in familial hypercholesterolemia: clinical management and concerns","volume":"28","author":"Hopkins","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacc.2018.05.044_bib129","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s40142-014-0036-8","article-title":"The role of genetic counselors for patients with familial hypercholesterolemia","volume":"2","author":"Sturm","year":"2014","journal-title":"Curr Genet Med Rep"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718350654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718350654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:15:51Z","timestamp":1760015751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109718350654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":128,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0735109718350654"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2018.05.044","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Genetic Testing for Familial\u00a0Hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2018.05.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}